nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—PTK2B—Alzheimer's disease	0.247	0.5	CbGaD
Sunitinib—LRRK2—Alzheimer's disease	0.247	0.5	CbGaD
Sunitinib—Procainamide—ACHE—Alzheimer's disease	0.000855	0.413	CrCbGaD
Sunitinib—Procainamide—BCHE—Alzheimer's disease	0.000503	0.243	CrCbGaD
Sunitinib—Metoclopramide—CYP2D6—Alzheimer's disease	0.000434	0.21	CrCbGaD
Sunitinib—Procainamide—CYP2D6—Alzheimer's disease	0.000276	0.133	CrCbGaD
Sunitinib—Urinary tract infection—Donepezil—Alzheimer's disease	0.00024	0.00144	CcSEcCtD
Sunitinib—Muscle spasms—Galantamine—Alzheimer's disease	0.000239	0.00143	CcSEcCtD
Sunitinib—Pancytopenia—Memantine—Alzheimer's disease	0.000239	0.00143	CcSEcCtD
Sunitinib—Bronchitis—Rivastigmine—Alzheimer's disease	0.000237	0.00142	CcSEcCtD
Sunitinib—Neutropenia—Memantine—Alzheimer's disease	0.000235	0.00141	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000234	0.0014	CcSEcCtD
Sunitinib—Epistaxis—Donepezil—Alzheimer's disease	0.000233	0.00139	CcSEcCtD
Sunitinib—Anaemia—Galantamine—Alzheimer's disease	0.00023	0.00138	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000229	0.00137	CcSEcCtD
Sunitinib—Weight decreased—Memantine—Alzheimer's disease	0.000228	0.00136	CcSEcCtD
Sunitinib—Hyperglycaemia—Memantine—Alzheimer's disease	0.000227	0.00136	CcSEcCtD
Sunitinib—Bradycardia—Donepezil—Alzheimer's disease	0.000226	0.00135	CcSEcCtD
Sunitinib—Pneumonia—Memantine—Alzheimer's disease	0.000226	0.00135	CcSEcCtD
Sunitinib—Infestation—Memantine—Alzheimer's disease	0.000224	0.00134	CcSEcCtD
Sunitinib—Infestation NOS—Memantine—Alzheimer's disease	0.000224	0.00134	CcSEcCtD
Sunitinib—Depression—Memantine—Alzheimer's disease	0.000224	0.00134	CcSEcCtD
Sunitinib—Haemoglobin—Donepezil—Alzheimer's disease	0.000223	0.00133	CcSEcCtD
Sunitinib—Weight decreased—Rivastigmine—Alzheimer's disease	0.000223	0.00133	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000222	0.00133	CcSEcCtD
Sunitinib—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000222	0.00133	CcSEcCtD
Sunitinib—Haemorrhage—Donepezil—Alzheimer's disease	0.000222	0.00133	CcSEcCtD
Sunitinib—Hepatitis—Donepezil—Alzheimer's disease	0.000222	0.00133	CcSEcCtD
Sunitinib—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000221	0.00132	CcSEcCtD
Sunitinib—Pneumonia—Rivastigmine—Alzheimer's disease	0.000221	0.00132	CcSEcCtD
Sunitinib—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000221	0.00132	CcSEcCtD
Sunitinib—Renal failure—Memantine—Alzheimer's disease	0.00022	0.00132	CcSEcCtD
Sunitinib—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00022	0.00131	CcSEcCtD
Sunitinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000219	0.00131	CcSEcCtD
Sunitinib—Infestation—Rivastigmine—Alzheimer's disease	0.000219	0.00131	CcSEcCtD
Sunitinib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000219	0.00131	CcSEcCtD
Sunitinib—Depression—Rivastigmine—Alzheimer's disease	0.000219	0.00131	CcSEcCtD
Sunitinib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000218	0.00131	CcSEcCtD
Sunitinib—Urinary tract infection—Memantine—Alzheimer's disease	0.000218	0.0013	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000217	0.0013	CcSEcCtD
Sunitinib—Urethral disorder—Donepezil—Alzheimer's disease	0.000217	0.0013	CcSEcCtD
Sunitinib—Cough—Galantamine—Alzheimer's disease	0.000217	0.0013	CcSEcCtD
Sunitinib—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000216	0.00129	CcSEcCtD
Sunitinib—Convulsion—Galantamine—Alzheimer's disease	0.000216	0.00129	CcSEcCtD
Sunitinib—Renal failure—Rivastigmine—Alzheimer's disease	0.000216	0.00129	CcSEcCtD
Sunitinib—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000215	0.00129	CcSEcCtD
Sunitinib—Hypertension—Galantamine—Alzheimer's disease	0.000215	0.00129	CcSEcCtD
Sunitinib—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000213	0.00128	CcSEcCtD
Sunitinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000212	0.00127	CcSEcCtD
Sunitinib—Chest pain—Galantamine—Alzheimer's disease	0.000212	0.00127	CcSEcCtD
Sunitinib—Arthralgia—Galantamine—Alzheimer's disease	0.000212	0.00127	CcSEcCtD
Sunitinib—Myalgia—Galantamine—Alzheimer's disease	0.000212	0.00127	CcSEcCtD
Sunitinib—Epistaxis—Memantine—Alzheimer's disease	0.000211	0.00127	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000211	0.00126	CcSEcCtD
Sunitinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000207	0.00124	CcSEcCtD
Sunitinib—Dry mouth—Galantamine—Alzheimer's disease	0.000207	0.00124	CcSEcCtD
Sunitinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000207	0.00124	CcSEcCtD
Sunitinib—Bradycardia—Memantine—Alzheimer's disease	0.000205	0.00123	CcSEcCtD
Sunitinib—Haemoglobin—Memantine—Alzheimer's disease	0.000202	0.00121	CcSEcCtD
Sunitinib—Haemorrhage—Memantine—Alzheimer's disease	0.000201	0.0012	CcSEcCtD
Sunitinib—Hepatitis—Memantine—Alzheimer's disease	0.000201	0.0012	CcSEcCtD
Sunitinib—Bradycardia—Rivastigmine—Alzheimer's disease	0.0002	0.0012	CcSEcCtD
Sunitinib—MAP3K19—central nervous system—Alzheimer's disease	0.0002	0.00156	CbGeAlD
Sunitinib—Hypoaesthesia—Memantine—Alzheimer's disease	0.0002	0.0012	CcSEcCtD
Sunitinib—HIPK2—cerebellum—Alzheimer's disease	0.0002	0.00156	CbGeAlD
Sunitinib—HIPK3—cerebellum—Alzheimer's disease	0.0002	0.00156	CbGeAlD
Sunitinib—TYRO3—cerebellum—Alzheimer's disease	0.0002	0.00156	CbGeAlD
Sunitinib—Shock—Galantamine—Alzheimer's disease	0.0002	0.0012	CcSEcCtD
Sunitinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000199	0.00119	CcSEcCtD
Sunitinib—KIT—embryo—Alzheimer's disease	0.000199	0.00155	CbGeAlD
Sunitinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000199	0.00119	CcSEcCtD
Sunitinib—Chills—Donepezil—Alzheimer's disease	0.000199	0.00119	CcSEcCtD
Sunitinib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000199	0.00119	CcSEcCtD
Sunitinib—KDR—forebrain—Alzheimer's disease	0.000199	0.00155	CbGeAlD
Sunitinib—Oedema peripheral—Memantine—Alzheimer's disease	0.000198	0.00119	CcSEcCtD
Sunitinib—Arrhythmia—Donepezil—Alzheimer's disease	0.000198	0.00118	CcSEcCtD
Sunitinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000198	0.00118	CcSEcCtD
Sunitinib—RIOK2—cerebellum—Alzheimer's disease	0.000198	0.00154	CbGeAlD
Sunitinib—TNK1—cerebellum—Alzheimer's disease	0.000198	0.00154	CbGeAlD
Sunitinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000198	0.00118	CcSEcCtD
Sunitinib—Skin disorder—Galantamine—Alzheimer's disease	0.000197	0.00118	CcSEcCtD
Sunitinib—Urethral disorder—Memantine—Alzheimer's disease	0.000197	0.00118	CcSEcCtD
Sunitinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000197	0.00118	CcSEcCtD
Sunitinib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000197	0.00118	CcSEcCtD
Sunitinib—DAPK3—central nervous system—Alzheimer's disease	0.000197	0.00153	CbGeAlD
Sunitinib—ROCK1—nervous system—Alzheimer's disease	0.000196	0.00153	CbGeAlD
Sunitinib—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000196	0.00117	CcSEcCtD
Sunitinib—Alopecia—Donepezil—Alzheimer's disease	0.000196	0.00117	CcSEcCtD
Sunitinib—CHEK2—brain—Alzheimer's disease	0.000195	0.00152	CbGeAlD
Sunitinib—NUAK1—brain—Alzheimer's disease	0.000195	0.00152	CbGeAlD
Sunitinib—CLK2—central nervous system—Alzheimer's disease	0.000195	0.00152	CbGeAlD
Sunitinib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000194	0.00116	CcSEcCtD
Sunitinib—PDGFRB—embryo—Alzheimer's disease	0.000194	0.00151	CbGeAlD
Sunitinib—Mental disorder—Donepezil—Alzheimer's disease	0.000194	0.00116	CcSEcCtD
Sunitinib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000194	0.00116	CcSEcCtD
Sunitinib—CSF1R—forebrain—Alzheimer's disease	0.000194	0.00151	CbGeAlD
Sunitinib—Anorexia—Galantamine—Alzheimer's disease	0.000194	0.00116	CcSEcCtD
Sunitinib—INSR—brain—Alzheimer's disease	0.000194	0.00151	CbGeAlD
Sunitinib—SNRK—brain—Alzheimer's disease	0.000194	0.00151	CbGeAlD
Sunitinib—OXSR1—brain—Alzheimer's disease	0.000194	0.00151	CbGeAlD
Sunitinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000194	0.00116	CcSEcCtD
Sunitinib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000193	0.00115	CcSEcCtD
Sunitinib—Erythema—Donepezil—Alzheimer's disease	0.000193	0.00115	CcSEcCtD
Sunitinib—Malnutrition—Donepezil—Alzheimer's disease	0.000193	0.00115	CcSEcCtD
Sunitinib—DAPK3—cerebellum—Alzheimer's disease	0.000192	0.0015	CbGeAlD
Sunitinib—DYRK1A—nervous system—Alzheimer's disease	0.000191	0.00149	CbGeAlD
Sunitinib—STK38—brain—Alzheimer's disease	0.000191	0.00148	CbGeAlD
Sunitinib—RPS6KA2—brain—Alzheimer's disease	0.000191	0.00148	CbGeAlD
Sunitinib—CLK2—cerebellum—Alzheimer's disease	0.00019	0.00148	CbGeAlD
Sunitinib—Erythema multiforme—Memantine—Alzheimer's disease	0.00019	0.00114	CcSEcCtD
Sunitinib—Flatulence—Donepezil—Alzheimer's disease	0.00019	0.00114	CcSEcCtD
Sunitinib—MAP4K2—cerebellum—Alzheimer's disease	0.000189	0.00147	CbGeAlD
Sunitinib—AURKC—brain—Alzheimer's disease	0.000189	0.00147	CbGeAlD
Sunitinib—Dysgeusia—Donepezil—Alzheimer's disease	0.000189	0.00113	CcSEcCtD
Sunitinib—ROCK1—central nervous system—Alzheimer's disease	0.000189	0.00147	CbGeAlD
Sunitinib—Eye disorder—Memantine—Alzheimer's disease	0.000188	0.00113	CcSEcCtD
Sunitinib—PKN1—brain—Alzheimer's disease	0.000188	0.00146	CbGeAlD
Sunitinib—CSNK1G2—brain—Alzheimer's disease	0.000188	0.00146	CbGeAlD
Sunitinib—STK3—cerebellum—Alzheimer's disease	0.000187	0.00145	CbGeAlD
Sunitinib—Cardiac disorder—Memantine—Alzheimer's disease	0.000187	0.00112	CcSEcCtD
Sunitinib—Flushing—Memantine—Alzheimer's disease	0.000187	0.00112	CcSEcCtD
Sunitinib—MERTK—nervous system—Alzheimer's disease	0.000187	0.00145	CbGeAlD
Sunitinib—Back pain—Donepezil—Alzheimer's disease	0.000187	0.00112	CcSEcCtD
Sunitinib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000186	0.00111	CcSEcCtD
Sunitinib—Muscle spasms—Donepezil—Alzheimer's disease	0.000186	0.00111	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000185	0.00111	CcSEcCtD
Sunitinib—PRPF4—brain—Alzheimer's disease	0.000185	0.00144	CbGeAlD
Sunitinib—DYRK1A—central nervous system—Alzheimer's disease	0.000184	0.00143	CbGeAlD
Sunitinib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000184	0.0011	CcSEcCtD
Sunitinib—Insomnia—Galantamine—Alzheimer's disease	0.000184	0.0011	CcSEcCtD
Sunitinib—MAP4K4—nervous system—Alzheimer's disease	0.000183	0.00143	CbGeAlD
Sunitinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000183	0.00109	CcSEcCtD
Sunitinib—Flushing—Rivastigmine—Alzheimer's disease	0.000183	0.00109	CcSEcCtD
Sunitinib—MAP2K5—telencephalon—Alzheimer's disease	0.000183	0.00142	CbGeAlD
Sunitinib—Angiopathy—Memantine—Alzheimer's disease	0.000183	0.00109	CcSEcCtD
Sunitinib—Paraesthesia—Galantamine—Alzheimer's disease	0.000182	0.00109	CcSEcCtD
Sunitinib—PRPF4B—brain—Alzheimer's disease	0.000182	0.00142	CbGeAlD
Sunitinib—Immune system disorder—Memantine—Alzheimer's disease	0.000182	0.00109	CcSEcCtD
Sunitinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000181	0.00109	CcSEcCtD
Sunitinib—MAP3K12—nervous system—Alzheimer's disease	0.000181	0.00141	CbGeAlD
Sunitinib—Chills—Memantine—Alzheimer's disease	0.000181	0.00108	CcSEcCtD
Sunitinib—DYRK1A—cerebellum—Alzheimer's disease	0.00018	0.0014	CbGeAlD
Sunitinib—Arrhythmia—Memantine—Alzheimer's disease	0.00018	0.00108	CcSEcCtD
Sunitinib—MERTK—central nervous system—Alzheimer's disease	0.00018	0.0014	CbGeAlD
Sunitinib—STK39—brain—Alzheimer's disease	0.00018	0.0014	CbGeAlD
Sunitinib—Dyspepsia—Galantamine—Alzheimer's disease	0.000179	0.00107	CcSEcCtD
Sunitinib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000179	0.00107	CcSEcCtD
Sunitinib—Anaemia—Donepezil—Alzheimer's disease	0.000178	0.00107	CcSEcCtD
Sunitinib—CSF1R—telencephalon—Alzheimer's disease	0.000178	0.00139	CbGeAlD
Sunitinib—RPS6KA3—nervous system—Alzheimer's disease	0.000178	0.00139	CbGeAlD
Sunitinib—Alopecia—Memantine—Alzheimer's disease	0.000178	0.00106	CcSEcCtD
Sunitinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000177	0.00106	CcSEcCtD
Sunitinib—CSNK2A1—brain—Alzheimer's disease	0.000177	0.00138	CbGeAlD
Sunitinib—MAP2K1—nervous system—Alzheimer's disease	0.000177	0.00138	CbGeAlD
Sunitinib—Chills—Rivastigmine—Alzheimer's disease	0.000177	0.00106	CcSEcCtD
Sunitinib—Decreased appetite—Galantamine—Alzheimer's disease	0.000177	0.00106	CcSEcCtD
Sunitinib—MAP4K4—central nervous system—Alzheimer's disease	0.000176	0.00137	CbGeAlD
Sunitinib—Mental disorder—Memantine—Alzheimer's disease	0.000176	0.00105	CcSEcCtD
Sunitinib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000176	0.00105	CcSEcCtD
Sunitinib—MERTK—cerebellum—Alzheimer's disease	0.000176	0.00137	CbGeAlD
Sunitinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000175	0.00105	CcSEcCtD
Sunitinib—Malnutrition—Memantine—Alzheimer's disease	0.000175	0.00105	CcSEcCtD
Sunitinib—Fatigue—Galantamine—Alzheimer's disease	0.000175	0.00105	CcSEcCtD
Sunitinib—MYLK—brain—Alzheimer's disease	0.000175	0.00136	CbGeAlD
Sunitinib—CSNK1A1—nervous system—Alzheimer's disease	0.000175	0.00136	CbGeAlD
Sunitinib—Alopecia—Rivastigmine—Alzheimer's disease	0.000174	0.00104	CcSEcCtD
Sunitinib—MAP3K12—central nervous system—Alzheimer's disease	0.000174	0.00135	CbGeAlD
Sunitinib—Constipation—Galantamine—Alzheimer's disease	0.000174	0.00104	CcSEcCtD
Sunitinib—CLK1—nervous system—Alzheimer's disease	0.000174	0.00135	CbGeAlD
Sunitinib—PLK4—brain—Alzheimer's disease	0.000173	0.00135	CbGeAlD
Sunitinib—Flatulence—Memantine—Alzheimer's disease	0.000173	0.00103	CcSEcCtD
Sunitinib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000173	0.00103	CcSEcCtD
Sunitinib—MAP4K4—cerebellum—Alzheimer's disease	0.000172	0.00134	CbGeAlD
Sunitinib—STK4—brain—Alzheimer's disease	0.000172	0.00134	CbGeAlD
Sunitinib—Dysgeusia—Memantine—Alzheimer's disease	0.000172	0.00103	CcSEcCtD
Sunitinib—RPS6KA3—central nervous system—Alzheimer's disease	0.000172	0.00134	CbGeAlD
Sunitinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000171	0.00103	CcSEcCtD
Sunitinib—Erythema—Rivastigmine—Alzheimer's disease	0.000171	0.00103	CcSEcCtD
Sunitinib—NUAK2—cerebellum—Alzheimer's disease	0.000171	0.00133	CbGeAlD
Sunitinib—MAP2K1—central nervous system—Alzheimer's disease	0.00017	0.00133	CbGeAlD
Sunitinib—BMP2K—nervous system—Alzheimer's disease	0.00017	0.00133	CbGeAlD
Sunitinib—CAMK2G—nervous system—Alzheimer's disease	0.00017	0.00133	CbGeAlD
Sunitinib—FLT3—cerebellum—Alzheimer's disease	0.00017	0.00132	CbGeAlD
Sunitinib—MAP3K12—cerebellum—Alzheimer's disease	0.00017	0.00132	CbGeAlD
Sunitinib—Back pain—Memantine—Alzheimer's disease	0.000169	0.00101	CcSEcCtD
Sunitinib—Flatulence—Rivastigmine—Alzheimer's disease	0.000169	0.00101	CcSEcCtD
Sunitinib—LRRK2—nervous system—Alzheimer's disease	0.000169	0.00131	CbGeAlD
Sunitinib—PHKG2—brain—Alzheimer's disease	0.000169	0.00131	CbGeAlD
Sunitinib—Cough—Donepezil—Alzheimer's disease	0.000168	0.00101	CcSEcCtD
Sunitinib—CSNK1A1—central nervous system—Alzheimer's disease	0.000168	0.00131	CbGeAlD
Sunitinib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000168	0.001	CcSEcCtD
Sunitinib—STK24—brain—Alzheimer's disease	0.000168	0.00131	CbGeAlD
Sunitinib—RPS6KA3—cerebellum—Alzheimer's disease	0.000168	0.00131	CbGeAlD
Sunitinib—Convulsion—Donepezil—Alzheimer's disease	0.000167	0.001	CcSEcCtD
Sunitinib—CLK1—central nervous system—Alzheimer's disease	0.000167	0.0013	CbGeAlD
Sunitinib—Hypertension—Donepezil—Alzheimer's disease	0.000167	0.000997	CcSEcCtD
Sunitinib—MAP2K1—cerebellum—Alzheimer's disease	0.000167	0.0013	CbGeAlD
Sunitinib—PRKAA1—nervous system—Alzheimer's disease	0.000166	0.0013	CbGeAlD
Sunitinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000166	0.000994	CcSEcCtD
Sunitinib—DAPK2—brain—Alzheimer's disease	0.000166	0.00129	CbGeAlD
Sunitinib—Back pain—Rivastigmine—Alzheimer's disease	0.000166	0.000992	CcSEcCtD
Sunitinib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000165	0.000986	CcSEcCtD
Sunitinib—PTK2B—nervous system—Alzheimer's disease	0.000165	0.00128	CbGeAlD
Sunitinib—CSNK1A1—cerebellum—Alzheimer's disease	0.000164	0.00128	CbGeAlD
Sunitinib—Chest pain—Donepezil—Alzheimer's disease	0.000164	0.000983	CcSEcCtD
Sunitinib—Arthralgia—Donepezil—Alzheimer's disease	0.000164	0.000983	CcSEcCtD
Sunitinib—Myalgia—Donepezil—Alzheimer's disease	0.000164	0.000983	CcSEcCtD
Sunitinib—BMP2K—central nervous system—Alzheimer's disease	0.000164	0.00128	CbGeAlD
Sunitinib—CAMK2G—central nervous system—Alzheimer's disease	0.000164	0.00128	CbGeAlD
Sunitinib—CLK1—cerebellum—Alzheimer's disease	0.000163	0.00127	CbGeAlD
Sunitinib—STK16—brain—Alzheimer's disease	0.000163	0.00127	CbGeAlD
Sunitinib—LRRK2—central nervous system—Alzheimer's disease	0.000163	0.00127	CbGeAlD
Sunitinib—HIPK3—brain—Alzheimer's disease	0.000162	0.00126	CbGeAlD
Sunitinib—HIPK2—brain—Alzheimer's disease	0.000162	0.00126	CbGeAlD
Sunitinib—TYRO3—brain—Alzheimer's disease	0.000162	0.00126	CbGeAlD
Sunitinib—ALK—brain—Alzheimer's disease	0.000162	0.00126	CbGeAlD
Sunitinib—Anaemia—Memantine—Alzheimer's disease	0.000162	0.000969	CcSEcCtD
Sunitinib—KIT—telencephalon—Alzheimer's disease	0.000162	0.00126	CbGeAlD
Sunitinib—CSNK1E—nervous system—Alzheimer's disease	0.000162	0.00126	CbGeAlD
Sunitinib—RIOK2—brain—Alzheimer's disease	0.000161	0.00125	CbGeAlD
Sunitinib—TNK1—brain—Alzheimer's disease	0.000161	0.00125	CbGeAlD
Sunitinib—Dry mouth—Donepezil—Alzheimer's disease	0.000161	0.000961	CcSEcCtD
Sunitinib—Abdominal pain—Galantamine—Alzheimer's disease	0.000161	0.000961	CcSEcCtD
Sunitinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000161	0.000961	CcSEcCtD
Sunitinib—CAMK2G—cerebellum—Alzheimer's disease	0.00016	0.00125	CbGeAlD
Sunitinib—BMP2K—cerebellum—Alzheimer's disease	0.00016	0.00125	CbGeAlD
Sunitinib—PRKAA1—central nervous system—Alzheimer's disease	0.00016	0.00125	CbGeAlD
Sunitinib—IRAK4—nervous system—Alzheimer's disease	0.000159	0.00124	CbGeAlD
Sunitinib—MAP4K1—brain—Alzheimer's disease	0.000159	0.00124	CbGeAlD
Sunitinib—MAP3K19—brain—Alzheimer's disease	0.000159	0.00124	CbGeAlD
Sunitinib—LRRK2—cerebellum—Alzheimer's disease	0.000159	0.00124	CbGeAlD
Sunitinib—PTK2B—central nervous system—Alzheimer's disease	0.000158	0.00123	CbGeAlD
Sunitinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000158	0.000948	CcSEcCtD
Sunitinib—PDGFRB—telencephalon—Alzheimer's disease	0.000158	0.00123	CbGeAlD
Sunitinib—Oedema—Donepezil—Alzheimer's disease	0.000158	0.000942	CcSEcCtD
Sunitinib—Leukopenia—Memantine—Alzheimer's disease	0.000157	0.000938	CcSEcCtD
Sunitinib—PRKAA1—cerebellum—Alzheimer's disease	0.000157	0.00122	CbGeAlD
Sunitinib—Infection—Donepezil—Alzheimer's disease	0.000156	0.000936	CcSEcCtD
Sunitinib—DAPK3—brain—Alzheimer's disease	0.000156	0.00121	CbGeAlD
Sunitinib—CSNK1E—central nervous system—Alzheimer's disease	0.000156	0.00121	CbGeAlD
Sunitinib—ULK3—nervous system—Alzheimer's disease	0.000156	0.00121	CbGeAlD
Sunitinib—MAP2K2—nervous system—Alzheimer's disease	0.000156	0.00121	CbGeAlD
Sunitinib—Shock—Donepezil—Alzheimer's disease	0.000155	0.000927	CcSEcCtD
Sunitinib—PTK2B—cerebellum—Alzheimer's disease	0.000155	0.00121	CbGeAlD
Sunitinib—MAP3K2—nervous system—Alzheimer's disease	0.000155	0.0012	CbGeAlD
Sunitinib—CLK2—brain—Alzheimer's disease	0.000155	0.0012	CbGeAlD
Sunitinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000154	0.000924	CcSEcCtD
Sunitinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000154	0.000922	CcSEcCtD
Sunitinib—MAP4K2—brain—Alzheimer's disease	0.000154	0.0012	CbGeAlD
Sunitinib—IRAK4—central nervous system—Alzheimer's disease	0.000153	0.00119	CbGeAlD
Sunitinib—Cough—Memantine—Alzheimer's disease	0.000153	0.000915	CcSEcCtD
Sunitinib—CSNK1E—cerebellum—Alzheimer's disease	0.000152	0.00119	CbGeAlD
Sunitinib—FGFR1—cerebellum—Alzheimer's disease	0.000152	0.00119	CbGeAlD
Sunitinib—Convulsion—Memantine—Alzheimer's disease	0.000152	0.000908	CcSEcCtD
Sunitinib—STK3—brain—Alzheimer's disease	0.000152	0.00118	CbGeAlD
Sunitinib—TBK1—nervous system—Alzheimer's disease	0.000152	0.00118	CbGeAlD
Sunitinib—Hypertension—Memantine—Alzheimer's disease	0.000151	0.000905	CcSEcCtD
Sunitinib—TYK2—nervous system—Alzheimer's disease	0.000151	0.00117	CbGeAlD
Sunitinib—Anorexia—Donepezil—Alzheimer's disease	0.00015	0.000898	CcSEcCtD
Sunitinib—MAP2K2—central nervous system—Alzheimer's disease	0.00015	0.00117	CbGeAlD
Sunitinib—ULK3—central nervous system—Alzheimer's disease	0.00015	0.00117	CbGeAlD
Sunitinib—IRAK4—cerebellum—Alzheimer's disease	0.00015	0.00117	CbGeAlD
Sunitinib—ROCK1—brain—Alzheimer's disease	0.00015	0.00117	CbGeAlD
Sunitinib—Hypersensitivity—Galantamine—Alzheimer's disease	0.00015	0.000896	CcSEcCtD
Sunitinib—Cough—Rivastigmine—Alzheimer's disease	0.00015	0.000895	CcSEcCtD
Sunitinib—Chest pain—Memantine—Alzheimer's disease	0.000149	0.000892	CcSEcCtD
Sunitinib—Myalgia—Memantine—Alzheimer's disease	0.000149	0.000892	CcSEcCtD
Sunitinib—Arthralgia—Memantine—Alzheimer's disease	0.000149	0.000892	CcSEcCtD
Sunitinib—MAP3K2—central nervous system—Alzheimer's disease	0.000149	0.00116	CbGeAlD
Sunitinib—Convulsion—Rivastigmine—Alzheimer's disease	0.000149	0.000888	CcSEcCtD
Sunitinib—Hypertension—Rivastigmine—Alzheimer's disease	0.000148	0.000885	CcSEcCtD
Sunitinib—MAP2K2—cerebellum—Alzheimer's disease	0.000147	0.00114	CbGeAlD
Sunitinib—ULK3—cerebellum—Alzheimer's disease	0.000147	0.00114	CbGeAlD
Sunitinib—DYRK1A—brain—Alzheimer's disease	0.000146	0.00114	CbGeAlD
Sunitinib—Chest pain—Rivastigmine—Alzheimer's disease	0.000146	0.000873	CcSEcCtD
Sunitinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000146	0.000873	CcSEcCtD
Sunitinib—Myalgia—Rivastigmine—Alzheimer's disease	0.000146	0.000873	CcSEcCtD
Sunitinib—Dry mouth—Memantine—Alzheimer's disease	0.000146	0.000873	CcSEcCtD
Sunitinib—TBK1—central nervous system—Alzheimer's disease	0.000146	0.00114	CbGeAlD
Sunitinib—Asthenia—Galantamine—Alzheimer's disease	0.000146	0.000872	CcSEcCtD
Sunitinib—RPS6KB1—nervous system—Alzheimer's disease	0.000146	0.00113	CbGeAlD
Sunitinib—MAP3K2—cerebellum—Alzheimer's disease	0.000146	0.00113	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000145	0.000867	CcSEcCtD
Sunitinib—TYK2—central nervous system—Alzheimer's disease	0.000145	0.00113	CbGeAlD
Sunitinib—FGR—nervous system—Alzheimer's disease	0.000145	0.00113	CbGeAlD
Sunitinib—RET—nervous system—Alzheimer's disease	0.000145	0.00113	CbGeAlD
Sunitinib—AXL—nervous system—Alzheimer's disease	0.000144	0.00112	CbGeAlD
Sunitinib—MAP3K7—cerebellum—Alzheimer's disease	0.000144	0.00112	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000143	0.000858	CcSEcCtD
Sunitinib—Oedema—Memantine—Alzheimer's disease	0.000143	0.000855	CcSEcCtD
Sunitinib—MERTK—brain—Alzheimer's disease	0.000143	0.00111	CbGeAlD
Sunitinib—Dry mouth—Rivastigmine—Alzheimer's disease	0.000143	0.000854	CcSEcCtD
Sunitinib—TBK1—cerebellum—Alzheimer's disease	0.000143	0.00111	CbGeAlD
Sunitinib—Insomnia—Donepezil—Alzheimer's disease	0.000142	0.000852	CcSEcCtD
Sunitinib—Infection—Memantine—Alzheimer's disease	0.000142	0.00085	CcSEcCtD
Sunitinib—TYK2—cerebellum—Alzheimer's disease	0.000142	0.0011	CbGeAlD
Sunitinib—Paraesthesia—Donepezil—Alzheimer's disease	0.000141	0.000846	CcSEcCtD
Sunitinib—Shock—Memantine—Alzheimer's disease	0.000141	0.000842	CcSEcCtD
Sunitinib—Dyspnoea—Donepezil—Alzheimer's disease	0.00014	0.00084	CcSEcCtD
Sunitinib—RPS6KB1—central nervous system—Alzheimer's disease	0.00014	0.00109	CbGeAlD
Sunitinib—Nervous system disorder—Memantine—Alzheimer's disease	0.00014	0.000839	CcSEcCtD
Sunitinib—MAP4K4—brain—Alzheimer's disease	0.00014	0.00109	CbGeAlD
Sunitinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.00014	0.000838	CcSEcCtD
Sunitinib—Oedema—Rivastigmine—Alzheimer's disease	0.00014	0.000837	CcSEcCtD
Sunitinib—IRAK1—cerebellum—Alzheimer's disease	0.00014	0.00109	CbGeAlD
Sunitinib—RET—central nervous system—Alzheimer's disease	0.000139	0.00109	CbGeAlD
Sunitinib—FGR—central nervous system—Alzheimer's disease	0.000139	0.00109	CbGeAlD
Sunitinib—NUAK2—brain—Alzheimer's disease	0.000139	0.00108	CbGeAlD
Sunitinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000139	0.000832	CcSEcCtD
Sunitinib—Infection—Rivastigmine—Alzheimer's disease	0.000139	0.000831	CcSEcCtD
Sunitinib—AXL—central nervous system—Alzheimer's disease	0.000139	0.00108	CbGeAlD
Sunitinib—Skin disorder—Memantine—Alzheimer's disease	0.000139	0.000831	CcSEcCtD
Sunitinib—Dyspepsia—Donepezil—Alzheimer's disease	0.000139	0.000829	CcSEcCtD
Sunitinib—MAP3K12—brain—Alzheimer's disease	0.000138	0.00107	CbGeAlD
Sunitinib—FGFR2—nervous system—Alzheimer's disease	0.000138	0.00107	CbGeAlD
Sunitinib—Shock—Rivastigmine—Alzheimer's disease	0.000138	0.000823	CcSEcCtD
Sunitinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000137	0.000821	CcSEcCtD
Sunitinib—RPS6KB1—cerebellum—Alzheimer's disease	0.000137	0.00107	CbGeAlD
Sunitinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000137	0.000819	CcSEcCtD
Sunitinib—ABCC4—forebrain—Alzheimer's disease	0.000137	0.00107	CbGeAlD
Sunitinib—JAK2—nervous system—Alzheimer's disease	0.000137	0.00107	CbGeAlD
Sunitinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000137	0.000819	CcSEcCtD
Sunitinib—RET—cerebellum—Alzheimer's disease	0.000136	0.00106	CbGeAlD
Sunitinib—Anorexia—Memantine—Alzheimer's disease	0.000136	0.000815	CcSEcCtD
Sunitinib—RPS6KA3—brain—Alzheimer's disease	0.000136	0.00106	CbGeAlD
Sunitinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000136	0.000813	CcSEcCtD
Sunitinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000136	0.000813	CcSEcCtD
Sunitinib—AXL—cerebellum—Alzheimer's disease	0.000136	0.00106	CbGeAlD
Sunitinib—Fatigue—Donepezil—Alzheimer's disease	0.000136	0.000812	CcSEcCtD
Sunitinib—MAP2K1—brain—Alzheimer's disease	0.000135	0.00105	CbGeAlD
Sunitinib—FYN—nervous system—Alzheimer's disease	0.000135	0.00105	CbGeAlD
Sunitinib—Constipation—Donepezil—Alzheimer's disease	0.000135	0.000806	CcSEcCtD
Sunitinib—Pain—Donepezil—Alzheimer's disease	0.000135	0.000806	CcSEcCtD
Sunitinib—Dizziness—Galantamine—Alzheimer's disease	0.000134	0.000804	CcSEcCtD
Sunitinib—CSNK1A1—brain—Alzheimer's disease	0.000134	0.00104	CbGeAlD
Sunitinib—Anorexia—Rivastigmine—Alzheimer's disease	0.000133	0.000798	CcSEcCtD
Sunitinib—CLK1—brain—Alzheimer's disease	0.000133	0.00103	CbGeAlD
Sunitinib—FGFR2—central nervous system—Alzheimer's disease	0.000133	0.00103	CbGeAlD
Sunitinib—MAP4K5—nervous system—Alzheimer's disease	0.000132	0.00103	CbGeAlD
Sunitinib—MAP3K3—nervous system—Alzheimer's disease	0.000132	0.00103	CbGeAlD
Sunitinib—JAK2—central nervous system—Alzheimer's disease	0.000132	0.00103	CbGeAlD
Sunitinib—SLK—cerebellum—Alzheimer's disease	0.000131	0.00102	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00013	0.000779	CcSEcCtD
Sunitinib—CAMK2G—brain—Alzheimer's disease	0.00013	0.00101	CbGeAlD
Sunitinib—BMP2K—brain—Alzheimer's disease	0.00013	0.00101	CbGeAlD
Sunitinib—FYN—central nervous system—Alzheimer's disease	0.00013	0.00101	CbGeAlD
Sunitinib—FGFR2—cerebellum—Alzheimer's disease	0.00013	0.00101	CbGeAlD
Sunitinib—Insomnia—Memantine—Alzheimer's disease	0.000129	0.000774	CcSEcCtD
Sunitinib—Vomiting—Galantamine—Alzheimer's disease	0.000129	0.000773	CcSEcCtD
Sunitinib—LRRK2—brain—Alzheimer's disease	0.000129	0.001	CbGeAlD
Sunitinib—JAK2—cerebellum—Alzheimer's disease	0.000129	0.001	CbGeAlD
Sunitinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000129	0.00077	CcSEcCtD
Sunitinib—Paraesthesia—Memantine—Alzheimer's disease	0.000128	0.000768	CcSEcCtD
Sunitinib—Rash—Galantamine—Alzheimer's disease	0.000128	0.000766	CcSEcCtD
Sunitinib—Dermatitis—Galantamine—Alzheimer's disease	0.000128	0.000766	CcSEcCtD
Sunitinib—FLT1—nervous system—Alzheimer's disease	0.000128	0.000993	CbGeAlD
Sunitinib—Dyspnoea—Memantine—Alzheimer's disease	0.000127	0.000763	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000127	0.000762	CcSEcCtD
Sunitinib—Headache—Galantamine—Alzheimer's disease	0.000127	0.000762	CcSEcCtD
Sunitinib—PRKAA1—brain—Alzheimer's disease	0.000127	0.00099	CbGeAlD
Sunitinib—FYN—cerebellum—Alzheimer's disease	0.000127	0.000989	CbGeAlD
Sunitinib—MAP3K3—central nervous system—Alzheimer's disease	0.000127	0.000989	CbGeAlD
Sunitinib—MAP4K5—central nervous system—Alzheimer's disease	0.000127	0.000989	CbGeAlD
Sunitinib—Insomnia—Rivastigmine—Alzheimer's disease	0.000127	0.000757	CcSEcCtD
Sunitinib—EPHB6—nervous system—Alzheimer's disease	0.000126	0.000982	CbGeAlD
Sunitinib—Dyspepsia—Memantine—Alzheimer's disease	0.000126	0.000753	CcSEcCtD
Sunitinib—PTK2B—brain—Alzheimer's disease	0.000126	0.000979	CbGeAlD
Sunitinib—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000126	0.000751	CcSEcCtD
Sunitinib—FLT4—brain—Alzheimer's disease	0.000125	0.000976	CbGeAlD
Sunitinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000125	0.000746	CcSEcCtD
Sunitinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000125	0.000745	CcSEcCtD
Sunitinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000125	0.000745	CcSEcCtD
Sunitinib—Decreased appetite—Memantine—Alzheimer's disease	0.000124	0.000744	CcSEcCtD
Sunitinib—MAP4K5—cerebellum—Alzheimer's disease	0.000124	0.000967	CbGeAlD
Sunitinib—MAP3K3—cerebellum—Alzheimer's disease	0.000124	0.000967	CbGeAlD
Sunitinib—CSNK1E—brain—Alzheimer's disease	0.000124	0.000963	CbGeAlD
Sunitinib—FGFR1—brain—Alzheimer's disease	0.000124	0.000963	CbGeAlD
Sunitinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000123	0.000739	CcSEcCtD
Sunitinib—Fatigue—Memantine—Alzheimer's disease	0.000123	0.000737	CcSEcCtD
Sunitinib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000123	0.000737	CcSEcCtD
Sunitinib—FLT1—central nervous system—Alzheimer's disease	0.000123	0.000956	CbGeAlD
Sunitinib—Pain—Memantine—Alzheimer's disease	0.000122	0.000731	CcSEcCtD
Sunitinib—Constipation—Memantine—Alzheimer's disease	0.000122	0.000731	CcSEcCtD
Sunitinib—YES1—nervous system—Alzheimer's disease	0.000122	0.000949	CbGeAlD
Sunitinib—IRAK4—brain—Alzheimer's disease	0.000122	0.000948	CbGeAlD
Sunitinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000122	0.000727	CcSEcCtD
Sunitinib—EPHB6—central nervous system—Alzheimer's disease	0.000121	0.000945	CbGeAlD
Sunitinib—STK10—nervous system—Alzheimer's disease	0.000121	0.00094	CbGeAlD
Sunitinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000121	0.000722	CcSEcCtD
Sunitinib—Nausea—Galantamine—Alzheimer's disease	0.000121	0.000722	CcSEcCtD
Sunitinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000121	0.000721	CcSEcCtD
Sunitinib—TAOK3—nervous system—Alzheimer's disease	0.00012	0.000937	CbGeAlD
Sunitinib—FLT1—cerebellum—Alzheimer's disease	0.00012	0.000935	CbGeAlD
Sunitinib—Pain—Rivastigmine—Alzheimer's disease	0.00012	0.000716	CcSEcCtD
Sunitinib—Constipation—Rivastigmine—Alzheimer's disease	0.00012	0.000716	CcSEcCtD
Sunitinib—PDGFRA—nervous system—Alzheimer's disease	0.00012	0.000931	CbGeAlD
Sunitinib—ULK3—brain—Alzheimer's disease	0.000119	0.000927	CbGeAlD
Sunitinib—MAP2K2—brain—Alzheimer's disease	0.000119	0.000927	CbGeAlD
Sunitinib—EPHB6—cerebellum—Alzheimer's disease	0.000119	0.000924	CbGeAlD
Sunitinib—MAP3K2—brain—Alzheimer's disease	0.000118	0.000921	CbGeAlD
Sunitinib—YES1—central nervous system—Alzheimer's disease	0.000117	0.000913	CbGeAlD
Sunitinib—MAP3K7—brain—Alzheimer's disease	0.000117	0.000912	CbGeAlD
Sunitinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000117	0.000699	CcSEcCtD
Sunitinib—STK10—central nervous system—Alzheimer's disease	0.000116	0.000905	CbGeAlD
Sunitinib—Hypersensitivity—Donepezil—Alzheimer's disease	0.000116	0.000694	CcSEcCtD
Sunitinib—TAOK3—central nervous system—Alzheimer's disease	0.000116	0.000902	CbGeAlD
Sunitinib—TBK1—brain—Alzheimer's disease	0.000116	0.000902	CbGeAlD
Sunitinib—PDGFRA—central nervous system—Alzheimer's disease	0.000115	0.000896	CbGeAlD
Sunitinib—TYK2—brain—Alzheimer's disease	0.000115	0.000895	CbGeAlD
Sunitinib—YES1—cerebellum—Alzheimer's disease	0.000115	0.000893	CbGeAlD
Sunitinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000114	0.000684	CcSEcCtD
Sunitinib—STK10—cerebellum—Alzheimer's disease	0.000114	0.000885	CbGeAlD
Sunitinib—IRAK1—brain—Alzheimer's disease	0.000114	0.000884	CbGeAlD
Sunitinib—TAOK3—cerebellum—Alzheimer's disease	0.000113	0.000881	CbGeAlD
Sunitinib—Body temperature increased—Memantine—Alzheimer's disease	0.000113	0.000676	CcSEcCtD
Sunitinib—Abdominal pain—Memantine—Alzheimer's disease	0.000113	0.000676	CcSEcCtD
Sunitinib—Asthenia—Donepezil—Alzheimer's disease	0.000113	0.000676	CcSEcCtD
Sunitinib—PDGFRA—cerebellum—Alzheimer's disease	0.000113	0.000876	CbGeAlD
Sunitinib—Pruritus—Donepezil—Alzheimer's disease	0.000111	0.000667	CcSEcCtD
Sunitinib—RPS6KB1—brain—Alzheimer's disease	0.000111	0.000867	CbGeAlD
Sunitinib—FGR—brain—Alzheimer's disease	0.000111	0.000862	CbGeAlD
Sunitinib—RET—brain—Alzheimer's disease	0.000111	0.000862	CbGeAlD
Sunitinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000111	0.000662	CcSEcCtD
Sunitinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000111	0.000662	CcSEcCtD
Sunitinib—AXL—brain—Alzheimer's disease	0.00011	0.000859	CbGeAlD
Sunitinib—KCNH2—forebrain—Alzheimer's disease	0.000109	0.000846	CbGeAlD
Sunitinib—KDR—nervous system—Alzheimer's disease	0.000108	0.00084	CbGeAlD
Sunitinib—MAP2K5—nervous system—Alzheimer's disease	0.000108	0.00084	CbGeAlD
Sunitinib—Diarrhoea—Donepezil—Alzheimer's disease	0.000108	0.000645	CcSEcCtD
Sunitinib—SLK—brain—Alzheimer's disease	0.000106	0.000826	CbGeAlD
Sunitinib—Hypersensitivity—Memantine—Alzheimer's disease	0.000105	0.00063	CcSEcCtD
Sunitinib—CSF1R—nervous system—Alzheimer's disease	0.000105	0.000819	CbGeAlD
Sunitinib—FGFR2—brain—Alzheimer's disease	0.000105	0.000819	CbGeAlD
Sunitinib—JAK2—brain—Alzheimer's disease	0.000105	0.000815	CbGeAlD
Sunitinib—Dizziness—Donepezil—Alzheimer's disease	0.000104	0.000623	CcSEcCtD
Sunitinib—MAP2K5—central nervous system—Alzheimer's disease	0.000104	0.000808	CbGeAlD
Sunitinib—KDR—central nervous system—Alzheimer's disease	0.000104	0.000808	CbGeAlD
Sunitinib—FYN—brain—Alzheimer's disease	0.000103	0.000804	CbGeAlD
Sunitinib—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000103	0.000617	CcSEcCtD
Sunitinib—Asthenia—Memantine—Alzheimer's disease	0.000103	0.000614	CcSEcCtD
Sunitinib—MAP2K5—cerebellum—Alzheimer's disease	0.000102	0.00079	CbGeAlD
Sunitinib—KDR—cerebellum—Alzheimer's disease	0.000102	0.00079	CbGeAlD
Sunitinib—CSF1R—central nervous system—Alzheimer's disease	0.000101	0.000789	CbGeAlD
Sunitinib—Pruritus—Memantine—Alzheimer's disease	0.000101	0.000605	CcSEcCtD
Sunitinib—MAP3K3—brain—Alzheimer's disease	0.000101	0.000785	CbGeAlD
Sunitinib—MAP4K5—brain—Alzheimer's disease	0.000101	0.000785	CbGeAlD
Sunitinib—Asthenia—Rivastigmine—Alzheimer's disease	0.0001	0.0006	CcSEcCtD
Sunitinib—Vomiting—Donepezil—Alzheimer's disease	0.0001	0.000599	CcSEcCtD
Sunitinib—KCNH2—telencephalon—Alzheimer's disease	9.99e-05	0.000778	CbGeAlD
Sunitinib—Rash—Donepezil—Alzheimer's disease	9.93e-05	0.000594	CcSEcCtD
Sunitinib—Dermatitis—Donepezil—Alzheimer's disease	9.92e-05	0.000593	CcSEcCtD
Sunitinib—CSF1R—cerebellum—Alzheimer's disease	9.91e-05	0.000771	CbGeAlD
Sunitinib—Pruritus—Rivastigmine—Alzheimer's disease	9.9e-05	0.000592	CcSEcCtD
Sunitinib—Headache—Donepezil—Alzheimer's disease	9.87e-05	0.00059	CcSEcCtD
Sunitinib—Diarrhoea—Memantine—Alzheimer's disease	9.78e-05	0.000585	CcSEcCtD
Sunitinib—FLT1—brain—Alzheimer's disease	9.75e-05	0.000759	CbGeAlD
Sunitinib—EPHB6—brain—Alzheimer's disease	9.64e-05	0.00075	CbGeAlD
Sunitinib—Diarrhoea—Rivastigmine—Alzheimer's disease	9.57e-05	0.000573	CcSEcCtD
Sunitinib—KIT—nervous system—Alzheimer's disease	9.56e-05	0.000744	CbGeAlD
Sunitinib—Dizziness—Memantine—Alzheimer's disease	9.46e-05	0.000566	CcSEcCtD
Sunitinib—Nausea—Donepezil—Alzheimer's disease	9.36e-05	0.00056	CcSEcCtD
Sunitinib—PDGFRB—nervous system—Alzheimer's disease	9.34e-05	0.000727	CbGeAlD
Sunitinib—YES1—brain—Alzheimer's disease	9.32e-05	0.000725	CbGeAlD
Sunitinib—Dizziness—Rivastigmine—Alzheimer's disease	9.25e-05	0.000553	CcSEcCtD
Sunitinib—STK10—brain—Alzheimer's disease	9.23e-05	0.000719	CbGeAlD
Sunitinib—KIT—central nervous system—Alzheimer's disease	9.2e-05	0.000716	CbGeAlD
Sunitinib—TAOK3—brain—Alzheimer's disease	9.2e-05	0.000716	CbGeAlD
Sunitinib—PDGFRA—brain—Alzheimer's disease	9.14e-05	0.000711	CbGeAlD
Sunitinib—Vomiting—Memantine—Alzheimer's disease	9.09e-05	0.000544	CcSEcCtD
Sunitinib—ABCB1—blood vessel—Alzheimer's disease	9.03e-05	0.000703	CbGeAlD
Sunitinib—Rash—Memantine—Alzheimer's disease	9.02e-05	0.000539	CcSEcCtD
Sunitinib—Dermatitis—Memantine—Alzheimer's disease	9.01e-05	0.000539	CcSEcCtD
Sunitinib—KIT—cerebellum—Alzheimer's disease	9e-05	0.0007	CbGeAlD
Sunitinib—PDGFRB—central nervous system—Alzheimer's disease	8.99e-05	0.0007	CbGeAlD
Sunitinib—Headache—Memantine—Alzheimer's disease	8.96e-05	0.000536	CcSEcCtD
Sunitinib—Vomiting—Rivastigmine—Alzheimer's disease	8.9e-05	0.000532	CcSEcCtD
Sunitinib—ABCG2—telencephalon—Alzheimer's disease	8.89e-05	0.000692	CbGeAlD
Sunitinib—Rash—Rivastigmine—Alzheimer's disease	8.82e-05	0.000528	CcSEcCtD
Sunitinib—Dermatitis—Rivastigmine—Alzheimer's disease	8.81e-05	0.000527	CcSEcCtD
Sunitinib—PDGFRB—cerebellum—Alzheimer's disease	8.79e-05	0.000684	CbGeAlD
Sunitinib—Headache—Rivastigmine—Alzheimer's disease	8.76e-05	0.000524	CcSEcCtD
Sunitinib—Nausea—Memantine—Alzheimer's disease	8.49e-05	0.000508	CcSEcCtD
Sunitinib—Nausea—Rivastigmine—Alzheimer's disease	8.31e-05	0.000497	CcSEcCtD
Sunitinib—KDR—brain—Alzheimer's disease	8.24e-05	0.000642	CbGeAlD
Sunitinib—MAP2K5—brain—Alzheimer's disease	8.24e-05	0.000642	CbGeAlD
Sunitinib—CSF1R—brain—Alzheimer's disease	8.05e-05	0.000626	CbGeAlD
Sunitinib—ABCC4—nervous system—Alzheimer's disease	7.43e-05	0.000579	CbGeAlD
Sunitinib—KIT—brain—Alzheimer's disease	7.31e-05	0.000569	CbGeAlD
Sunitinib—ABCC4—central nervous system—Alzheimer's disease	7.16e-05	0.000557	CbGeAlD
Sunitinib—PDGFRB—brain—Alzheimer's disease	7.14e-05	0.000555	CbGeAlD
Sunitinib—KCNH2—nervous system—Alzheimer's disease	5.9e-05	0.000459	CbGeAlD
Sunitinib—ABCC4—brain—Alzheimer's disease	5.68e-05	0.000442	CbGeAlD
Sunitinib—KCNH2—central nervous system—Alzheimer's disease	5.68e-05	0.000442	CbGeAlD
Sunitinib—KCNH2—cerebellum—Alzheimer's disease	5.55e-05	0.000432	CbGeAlD
Sunitinib—ABCB1—embryo—Alzheimer's disease	5.39e-05	0.000419	CbGeAlD
Sunitinib—ABCG2—cerebellum—Alzheimer's disease	4.94e-05	0.000384	CbGeAlD
Sunitinib—ABCB1—forebrain—Alzheimer's disease	4.77e-05	0.000371	CbGeAlD
Sunitinib—KCNH2—brain—Alzheimer's disease	4.51e-05	0.000351	CbGeAlD
Sunitinib—ABCB1—telencephalon—Alzheimer's disease	4.38e-05	0.000341	CbGeAlD
Sunitinib—ABCG2—brain—Alzheimer's disease	4.01e-05	0.000312	CbGeAlD
Sunitinib—CYP3A4—nervous system—Alzheimer's disease	3.66e-05	0.000285	CbGeAlD
Sunitinib—CYP3A4—central nervous system—Alzheimer's disease	3.52e-05	0.000274	CbGeAlD
Sunitinib—ABCB1—nervous system—Alzheimer's disease	2.59e-05	0.000201	CbGeAlD
Sunitinib—ABCB1—central nervous system—Alzheimer's disease	2.49e-05	0.000194	CbGeAlD
Sunitinib—ABCB1—cerebellum—Alzheimer's disease	2.44e-05	0.00019	CbGeAlD
Sunitinib—ABCB1—brain—Alzheimer's disease	1.98e-05	0.000154	CbGeAlD
Sunitinib—JAK2—Signaling Pathways—GSK3B—Alzheimer's disease	6.39e-07	3.06e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—Alzheimer's disease	6.39e-07	3.06e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1—Alzheimer's disease	6.38e-07	3.05e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CASP3—Alzheimer's disease	6.38e-07	3.05e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—AKT1—Alzheimer's disease	6.36e-07	3.04e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	6.35e-07	3.04e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—INS—Alzheimer's disease	6.34e-07	3.04e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—Alzheimer's disease	6.34e-07	3.04e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CREB1—Alzheimer's disease	6.34e-07	3.04e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—Alzheimer's disease	6.33e-07	3.03e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—AKT1—Alzheimer's disease	6.31e-07	3.02e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—INS—Alzheimer's disease	6.31e-07	3.02e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCL2—Alzheimer's disease	6.2e-07	2.97e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CASP3—Alzheimer's disease	6.2e-07	2.97e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—Alzheimer's disease	6.19e-07	2.96e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—Alzheimer's disease	6.19e-07	2.96e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOS3—Alzheimer's disease	6.19e-07	2.96e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK8—Alzheimer's disease	6.18e-07	2.96e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	6.16e-07	2.95e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—Alzheimer's disease	6.16e-07	2.95e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.14e-07	2.94e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.14e-07	2.94e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CASP3—Alzheimer's disease	6.12e-07	2.93e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—Alzheimer's disease	6.11e-07	2.92e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1—Alzheimer's disease	6.1e-07	2.92e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—Alzheimer's disease	6.05e-07	2.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOS3—Alzheimer's disease	6.04e-07	2.89e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—Alzheimer's disease	6.04e-07	2.89e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CASP3—Alzheimer's disease	6.01e-07	2.88e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CASP3—Alzheimer's disease	6.01e-07	2.88e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—Alzheimer's disease	6e-07	2.87e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—Alzheimer's disease	5.9e-07	2.83e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.89e-07	2.82e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK8—Alzheimer's disease	5.87e-07	2.81e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—Alzheimer's disease	5.84e-07	2.8e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOS3—Alzheimer's disease	5.82e-07	2.78e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—Alzheimer's disease	5.79e-07	2.77e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOS3—Alzheimer's disease	5.79e-07	2.77e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	5.76e-07	2.76e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—Alzheimer's disease	5.71e-07	2.73e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CASP3—Alzheimer's disease	5.7e-07	2.73e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—Alzheimer's disease	5.7e-07	2.73e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK8—Alzheimer's disease	5.69e-07	2.73e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CASP3—Alzheimer's disease	5.69e-07	2.72e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AKT1—Alzheimer's disease	5.68e-07	2.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.67e-07	2.71e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—AKT1—Alzheimer's disease	5.63e-07	2.7e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—Alzheimer's disease	5.62e-07	2.69e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK8—Alzheimer's disease	5.62e-07	2.69e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—NOS3—Alzheimer's disease	5.61e-07	2.69e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—NOS3—Alzheimer's disease	5.56e-07	2.66e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—Alzheimer's disease	5.55e-07	2.66e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—Alzheimer's disease	5.54e-07	2.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOS3—Alzheimer's disease	5.53e-07	2.65e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK8—Alzheimer's disease	5.52e-07	2.64e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK8—Alzheimer's disease	5.52e-07	2.64e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—Alzheimer's disease	5.49e-07	2.63e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—Alzheimer's disease	5.49e-07	2.63e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—Alzheimer's disease	5.49e-07	2.63e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.47e-07	2.62e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—Alzheimer's disease	5.46e-07	2.62e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—Alzheimer's disease	5.45e-07	2.61e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—Alzheimer's disease	5.45e-07	2.61e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—Alzheimer's disease	5.45e-07	2.61e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—Alzheimer's disease	5.42e-07	2.59e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CALM1—Alzheimer's disease	5.39e-07	2.58e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—Alzheimer's disease	5.37e-07	2.57e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—Alzheimer's disease	5.34e-07	2.56e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CAV1—Alzheimer's disease	5.32e-07	2.55e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.31e-07	2.54e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—Alzheimer's disease	5.29e-07	2.53e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.28e-07	2.53e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—Alzheimer's disease	5.26e-07	2.52e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—Alzheimer's disease	5.26e-07	2.52e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CASP3—Alzheimer's disease	5.25e-07	2.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK8—Alzheimer's disease	5.24e-07	2.51e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—Alzheimer's disease	5.24e-07	2.51e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK8—Alzheimer's disease	5.23e-07	2.5e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—Alzheimer's disease	5.22e-07	2.5e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—Alzheimer's disease	5.22e-07	2.5e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—Alzheimer's disease	5.19e-07	2.49e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—Alzheimer's disease	5.19e-07	2.48e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—Alzheimer's disease	5.19e-07	2.48e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—Alzheimer's disease	5.18e-07	2.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—Alzheimer's disease	5.16e-07	2.47e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—Alzheimer's disease	5.13e-07	2.46e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—Alzheimer's disease	5.13e-07	2.45e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CASP3—Alzheimer's disease	5.12e-07	2.45e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—Alzheimer's disease	5.12e-07	2.45e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—Alzheimer's disease	5.11e-07	2.45e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—Alzheimer's disease	5.1e-07	2.44e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—Alzheimer's disease	5.1e-07	2.44e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—Alzheimer's disease	5.1e-07	2.44e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—Alzheimer's disease	5.1e-07	2.44e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	5.09e-07	2.43e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—Alzheimer's disease	5.06e-07	2.42e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—Alzheimer's disease	5.04e-07	2.41e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—Alzheimer's disease	5.03e-07	2.41e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—Alzheimer's disease	5.03e-07	2.41e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—Alzheimer's disease	5.03e-07	2.41e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—Alzheimer's disease	4.97e-07	2.38e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—Alzheimer's disease	4.97e-07	2.38e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CASP3—Alzheimer's disease	4.94e-07	2.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CASP3—Alzheimer's disease	4.91e-07	2.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—Alzheimer's disease	4.88e-07	2.34e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—Alzheimer's disease	4.84e-07	2.32e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—Alzheimer's disease	4.84e-07	2.32e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LPL—Alzheimer's disease	4.83e-07	2.31e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—Alzheimer's disease	4.83e-07	2.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK8—Alzheimer's disease	4.83e-07	2.31e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—Alzheimer's disease	4.83e-07	2.31e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—Alzheimer's disease	4.81e-07	2.3e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—Alzheimer's disease	4.81e-07	2.3e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—Alzheimer's disease	4.79e-07	2.29e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—Alzheimer's disease	4.78e-07	2.29e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—Alzheimer's disease	4.78e-07	2.29e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—Alzheimer's disease	4.77e-07	2.28e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—Alzheimer's disease	4.77e-07	2.28e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—Alzheimer's disease	4.77e-07	2.28e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—Alzheimer's disease	4.76e-07	2.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.76e-07	2.28e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.74e-07	2.27e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—Alzheimer's disease	4.73e-07	2.26e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK8—Alzheimer's disease	4.71e-07	2.25e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.71e-07	2.25e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—Alzheimer's disease	4.7e-07	2.25e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—Alzheimer's disease	4.68e-07	2.24e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—Alzheimer's disease	4.68e-07	2.24e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—Alzheimer's disease	4.67e-07	2.24e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—Alzheimer's disease	4.67e-07	2.23e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—Alzheimer's disease	4.67e-07	2.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—Alzheimer's disease	4.66e-07	2.23e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—Alzheimer's disease	4.65e-07	2.23e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—Alzheimer's disease	4.65e-07	2.22e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—Alzheimer's disease	4.64e-07	2.22e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—INS—Alzheimer's disease	4.58e-07	2.19e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—Alzheimer's disease	4.55e-07	2.18e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK8—Alzheimer's disease	4.54e-07	2.17e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK8—Alzheimer's disease	4.52e-07	2.16e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—Alzheimer's disease	4.5e-07	2.16e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—Alzheimer's disease	4.48e-07	2.15e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—Alzheimer's disease	4.47e-07	2.14e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.46e-07	2.14e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.46e-07	2.14e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—Alzheimer's disease	4.46e-07	2.13e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—Alzheimer's disease	4.46e-07	2.13e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—Alzheimer's disease	4.44e-07	2.13e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—Alzheimer's disease	4.44e-07	2.13e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—Alzheimer's disease	4.43e-07	2.12e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—Alzheimer's disease	4.41e-07	2.11e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—Alzheimer's disease	4.4e-07	2.11e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—Alzheimer's disease	4.4e-07	2.1e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—Alzheimer's disease	4.4e-07	2.1e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.38e-07	2.09e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.35e-07	2.08e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—Alzheimer's disease	4.35e-07	2.08e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK8—Alzheimer's disease	4.32e-07	2.07e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—Alzheimer's disease	4.31e-07	2.06e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—Alzheimer's disease	4.31e-07	2.06e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—Alzheimer's disease	4.31e-07	2.06e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—Alzheimer's disease	4.3e-07	2.06e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—Alzheimer's disease	4.29e-07	2.06e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—Alzheimer's disease	4.29e-07	2.05e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—Alzheimer's disease	4.26e-07	2.04e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—Alzheimer's disease	4.2e-07	2.01e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—Alzheimer's disease	4.19e-07	2.01e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—Alzheimer's disease	4.17e-07	2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.15e-07	1.99e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—Alzheimer's disease	4.14e-07	1.98e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—Alzheimer's disease	4.14e-07	1.98e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—Alzheimer's disease	4.12e-07	1.97e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—Alzheimer's disease	4.11e-07	1.97e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—Alzheimer's disease	4.09e-07	1.96e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—Alzheimer's disease	4.09e-07	1.96e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.06e-07	1.95e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—Alzheimer's disease	4.06e-07	1.94e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—Alzheimer's disease	4.05e-07	1.94e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—Alzheimer's disease	4.02e-07	1.92e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.01e-07	1.92e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—Alzheimer's disease	3.99e-07	1.91e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—Alzheimer's disease	3.98e-07	1.91e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—Alzheimer's disease	3.97e-07	1.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—Alzheimer's disease	3.96e-07	1.9e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—Alzheimer's disease	3.95e-07	1.89e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—Alzheimer's disease	3.94e-07	1.88e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—Alzheimer's disease	3.93e-07	1.88e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—Alzheimer's disease	3.92e-07	1.88e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.91e-07	1.87e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—Alzheimer's disease	3.85e-07	1.84e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—Alzheimer's disease	3.85e-07	1.84e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—Alzheimer's disease	3.85e-07	1.84e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—Alzheimer's disease	3.83e-07	1.83e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—Alzheimer's disease	3.82e-07	1.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—Alzheimer's disease	3.8e-07	1.82e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.79e-07	1.82e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—Alzheimer's disease	3.75e-07	1.79e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	3.68e-07	1.76e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—Alzheimer's disease	3.66e-07	1.75e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—Alzheimer's disease	3.66e-07	1.75e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—Alzheimer's disease	3.65e-07	1.75e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—Alzheimer's disease	3.64e-07	1.74e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—Alzheimer's disease	3.64e-07	1.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—Alzheimer's disease	3.63e-07	1.74e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—Alzheimer's disease	3.59e-07	1.72e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.53e-07	1.69e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—Alzheimer's disease	3.53e-07	1.69e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—Alzheimer's disease	3.53e-07	1.69e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—INS—Alzheimer's disease	3.46e-07	1.66e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—Alzheimer's disease	3.46e-07	1.65e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—Alzheimer's disease	3.37e-07	1.61e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—Alzheimer's disease	3.35e-07	1.61e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—Alzheimer's disease	3.35e-07	1.6e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—Alzheimer's disease	3.34e-07	1.6e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—Alzheimer's disease	3.31e-07	1.59e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—Alzheimer's disease	3.29e-07	1.57e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.27e-07	1.56e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.25e-07	1.56e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—Alzheimer's disease	3.25e-07	1.56e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—Alzheimer's disease	3.25e-07	1.56e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—Alzheimer's disease	3.17e-07	1.52e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—Alzheimer's disease	3.15e-07	1.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—Alzheimer's disease	3.09e-07	1.48e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—Alzheimer's disease	3.08e-07	1.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—Alzheimer's disease	3.08e-07	1.47e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.03e-07	1.45e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—Alzheimer's disease	3.01e-07	1.44e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—Alzheimer's disease	3.01e-07	1.44e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.98e-07	1.42e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—Alzheimer's disease	2.9e-07	1.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—Alzheimer's disease	2.88e-07	1.38e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—Alzheimer's disease	2.84e-07	1.36e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.77e-07	1.33e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—Alzheimer's disease	2.77e-07	1.33e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—Alzheimer's disease	2.76e-07	1.32e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.68e-07	1.28e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—Alzheimer's disease	2.67e-07	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—Alzheimer's disease	2.66e-07	1.27e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—Alzheimer's disease	2.58e-07	1.23e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—Alzheimer's disease	2.56e-07	1.22e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—Alzheimer's disease	2.54e-07	1.22e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.5e-07	1.2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.5e-07	1.19e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.47e-07	1.18e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.17e-07	1.04e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INS—Alzheimer's disease	2.13e-07	1.02e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.87e-07	8.95e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.85e-07	8.85e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.71e-07	8.18e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.39e-07	6.68e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.59e-08	4.11e-07	CbGpPWpGaD
